solution by MARKET
Pharmaceutical Production Lines & Turnkey Factory Solutions for Tanzania
From IV solution filling lines and OSD plants to injectable systems and medical device machinery — GMP-compliant manufacturing infrastructure built for East Africa’s fastest-emerging pharmaceutical hub.
A Clear View of the Local Market Landscape
Tanzania has spent more than $1.5 billion on importing pharmaceutical products over the past five years, yet the country currently has only 11 factories dedicated to pharmaceutical manufacturing, with local production meeting just 10–20% of national demand — meaning up to 80% of all drugs and medical supplies are imported. In December 2025, the Government of Tanzania announced a formal policy shift to accelerate domestic pharmaceutical manufacturing, with the objective of positioning the country as a regional pharmaceutical manufacturing hub — planning 10 new factories for ARVs, tablets, injectables, drips and reagents, and creating massive demand for new GMP-compliant production facilities, equipment, and turnkey factory infrastructure.

Demand Trends Within the Country
-
National Pharmaceutical Localization Push
The Government has introduced a Green-Lane Approval System under the Pharmaceutical Investment Acceleration Programme to fast-track strategic pharmaceutical investments, driving urgent demand for new production lines and complete factory builds -
Injectable & IV Solution Production
With a population of ~65 million and expanding healthcare infrastructure, Tanzania critically needs locally produced IV fluids, injectable antibiotics, antimalarials, ARVs, and vaccines to replace its massive import bill. -
OSD & Generic Drug Manufacturing
The growth of the generic drug segment is a major market trend, driven by the government’s efforts to increase access to affordable healthcare and policies encouraging the use of generic drugs in public health facilities. -
Medical Consumables & Diagnostics
The government initiative explicitly targets local production of essential medicines, vaccines, biologics, APIs, medical consumables, and specialized formulations — creating demand for locally assembled blood collection tubes, syringes, and blood bags.
Local Experience, Reliable Execution
-
Proven East Africa delivery track record — 2,500+ production lines deployed in 60+ countries, with deep experience across Sub-Saharan African pharmaceutical and medical device markets, including completed projects in Tanzania.
-
TMDA & WHO GMP alignment — All systems pre-engineered to meet WHO GMP, EU GMP, and PIC/S GMP standards, fully aligned with TMDA inspection requirements. Tanzania made history in 2018 when TMDA became the first regulatory authority in Africa to attain WHO Maturity Level 3 status, and our systems are designed to meet this benchmark.
-
Full turnkey EPC capability — From consulting and process design through equipment manufacturing, cleanroom construction, utility installation, IQ/OQ/PQ validation, technology transfer, and operator training — one partner, one contract.
-
Customized for Tanzania’s strategic priorities — Solutions tailored for high-burden therapeutic areas (HIV/AIDS, malaria, TB, infectious diseases) and configured to support the government’s regional pharmaceutical hub ambitions targeting EAC and SADC export markets.
Selected Products for This Market
Meeting Local Standards with Reliable Delivery
Compliance & Certification
Logistics & Delivery
Success Snapshot
-
Pharmaceutical Manufacturer
Delivered a PP bottle IV solution production line with pharmaceutical water system, cleanroom, and automated packaging. The facility passed TMDA GMP inspection and achieved annual production of 10 million bottles of IV solution, supplying MSD and private-sector distribution channels across the country.
-
Healthcare Investment Group
Supplied an integrated OSD plant including tablet and capsule lines, purified water system, and blister packaging for production of antimalarials, antibiotics, and essential generics. The project was completed in 15 months, achieving TMDA GMP certification and enabling the client to serve both the domestic market and EAC regional export.
Trusted by Local Customers
-
“IVEN delivered our complete IV solution facility — water system, cleanroom, filling line, and packaging — under one turnkey contract. Their understanding of TMDA requirements and WHO GMP standards meant we passed inspection on the first audit and were producing within 14 months.”
Mr. M
Managing Director
-
“Their OSD factory solution was exactly what we needed to support Tanzania’s essential medicines program. The technology transfer and staff training were exceptionally thorough — our Tanzanian operators were fully independent within weeks.”
Dr. J
Plant Director













